Blood samples to study peanut and tree nut allergies
Part of Immune system & allergy clinical trials.
This study collects blood (or uses already-collected blood) to learn why peanut, tree nut, and related food allergies happen and how they behave during challenges. It may help researchers better understand allergies and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 75 years old (depending on the group)
- You have peanut allergy and a history of a whole-body (systemic) reaction, or you’re a peanut allergy normal-control group
- Or you have tree nut or other food allergies with a history of a whole-body reaction
- Or you are currently undergoing a medically needed peanut food challenge
- Or you participated in a peanut oral immunotherapy (OIT) trial and had at least one oral challenge
- You do not have a major medical or psychiatric condition known to affect the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test to help diagnose peanut allergy. If you are already having blood drawn, they will take two extra small tubes of blood to see how well the test works.
This study tests a treatment that gradually exposes children to small amounts of peanut and certain tree nuts to reduce their allergy. It aims to help children safely tolerate multiple nuts at once.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
This trial tests an investigational medication called LP-003 to see if it can reduce allergic reactions to peanuts. It may help people who are allergic to peanuts be able to tolerate small amounts.
This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.
This study tests how a specific form of treatment is given to people with a tree nut allergy. The goal is to find a safer, more effective way to help your body tolerate tree nuts.
Hear when a new Peanut Allergies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.